Richard Johnson
Directeur Financier/CFO chez Phibro Animal Health (Belgium) SA
Profil
Richard G.
Johnson is currently the Chief Financial Officer at Phibro Animal Health (Belgium) SA. Previously, he held the same position at Phibro Animal Health Corp.
from 2002 to 2020.
Prior to that, he was the Vice President of Planning & Control at Ecolab, Inc. from 1992 to 1999 and the Director of Financial Management at Laserdyne Prima, Inc. from 2000 to 2002.
In 2023, he will return to Phibro Animal Health Corp.
as their Chief Financial Officer for a one-year term.
Postes actifs de Richard Johnson
| Sociétés | Poste | Début |
|---|---|---|
Phibro Animal Health (Belgium) SA
 Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium | Directeur Financier/CFO | 08/06/2011 |
Anciens postes connus de Richard Johnson
| Sociétés | Poste | Fin |
|---|---|---|
| PHIBRO ANIMAL HEALTH CORPORATION | Directeur Financier/CFO | 09/02/2024 |
| PHIBRO ANIMAL HEALTH CORPORATION | Directeur Financier/CFO | 15/11/2020 |
| Laserdyne Prima, Inc. | Corporate Officer/Principal | 01/01/2002 |
| ECOLAB INC. | Corporate Officer/Principal | 01/01/1999 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ECOLAB INC. | Process Industries |
| PHIBRO ANIMAL HEALTH CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Laserdyne Prima, Inc. | |
Phibro Animal Health (Belgium) SA
Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium | Process Industries |
